219 related articles for article (PubMed ID: 36699667)
1. Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer.
Christensen TD; Maag E; Larsen O; Feltoft CL; Nielsen KR; Jensen LH; Leerhøy B; Hansen CP; Chen IM; Nielsen DL; Johansen JS
JHEP Rep; 2023 Mar; 5(3):100648. PubMed ID: 36699667
[TBL] [Abstract][Full Text] [Related]
2. Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer.
Christensen TD; Madsen K; Maag E; Larsen O; Jensen LH; Hansen CP; Markussen A; Høgdall DTS; Chen IM; Nielsen D; Johansen JS
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831406
[TBL] [Abstract][Full Text] [Related]
3. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
4. The present roles and future perspectives of Interleukin-6 in biliary tract cancer.
Zhou M; Na R; Lai S; Guo Y; Shi J; Nie J; Zhang S; Wang Y; Zheng T
Cytokine; 2023 Sep; 169():156271. PubMed ID: 37331095
[TBL] [Abstract][Full Text] [Related]
5. A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.
Sandanayake NS; Sinclair J; Andreola F; Chapman MH; Xue A; Webster GJ; Clarkson A; Gill A; Norton ID; Smith RC; Timms JF; Pereira SP
Br J Cancer; 2011 Oct; 105(9):1370-8. PubMed ID: 21970875
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer.
Loosen SH; Breuer A; Tacke F; Kather JN; Gorgulho J; Alizai PH; Bednarsch J; Roeth AA; Lurje G; Schmitz SM; Brozat JF; Paffenholz P; Vucur M; Ritz T; Koch A; Trautwein C; Ulmer TF; Roderburg C; Longerich T; Neumann UP; Luedde T
JHEP Rep; 2020 Apr; 2(2):100080. PubMed ID: 32140677
[TBL] [Abstract][Full Text] [Related]
7. Whole blood microRNAs capture systemic reprogramming and have diagnostic potential in patients with biliary tract cancer.
Høgdall D; O'Rourke CJ; Larsen FO; Zarforoushan S; Christensen TD; Ghazal A; Boisen MK; Muñoz-Garrido P; Johansen JS; Andersen JB
J Hepatol; 2022 Oct; 77(4):1047-1058. PubMed ID: 35750139
[TBL] [Abstract][Full Text] [Related]
8. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Leelawat K; Sakchinabut S; Narong S; Wannaprasert J
BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942
[TBL] [Abstract][Full Text] [Related]
9. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
J Gastrointest Cancer; 2024 Jan; ():. PubMed ID: 38280173
[TBL] [Abstract][Full Text] [Related]
10. Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.
Christensen TD; Jensen C; Larsen O; Leerhøy B; Hansen CP; Madsen K; Høgdall D; Karsdal MA; Chen IM; Nielsen D; Johansen JS; Willumsen N
Int J Cancer; 2023 Mar; 152(5):1036-1049. PubMed ID: 36455598
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential serum peptide biomarkers of biliary tract cancer using MALDI MS profiling.
Sandanayake NS; Camuzeaux S; Sinclair J; Blyuss O; Andreola F; Chapman MH; Webster GJ; Smith RC; Timms JF; Pereira SP
BMC Clin Pathol; 2014 Feb; 14(1):7. PubMed ID: 24495412
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Novel Biomarker for Biliary Tract Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
Kikkawa S; Sogawa K; Satoh M; Umemura H; Kodera Y; Matsushita K; Tomonaga T; Miyazaki M; Yokosuka O; Nomura F
Int J Proteomics; 2012; 2012():108609. PubMed ID: 22888427
[TBL] [Abstract][Full Text] [Related]
13. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer.
Kishimoto T; Eguchi H; Nagano H; Kobayashi S; Akita H; Hama N; Wada H; Kawamoto K; Tomokuni A; Tomimaru Y; Umeshita K; Doki Y; Mori M
Cancer Sci; 2013 Dec; 104(12):1626-31. PubMed ID: 24118467
[TBL] [Abstract][Full Text] [Related]
14. Identification of a serum biomarker panel for the differential diagnosis of cholangiocarcinoma and primary sclerosing cholangitis.
Cuenco J; Wehnert N; Blyuss O; Kazarian A; Whitwell HJ; Menon U; Dawnay A; Manns MP; Pereira SP; Timms JF
Oncotarget; 2018 Apr; 9(25):17430-17442. PubMed ID: 29707118
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapies for Perihilar Cholangiocarcinoma.
Gray S; Lamarca A; Edeline J; Klümpen HJ; Hubner RA; McNamara MG; Valle JW
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406560
[TBL] [Abstract][Full Text] [Related]
16. Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases.
Leelawat K; Narong S; Wannaprasert J; Leelawat S
Int J Hepatol; 2011; 2011():873548. PubMed ID: 21994874
[TBL] [Abstract][Full Text] [Related]
17. Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer.
Loosen SH; Ulmer TF; Labuhn S; Bednarsch J; Lang SA; Alizai PH; Schneider AT; Vucur M; Neumann UP; Luedde T; Roderburg C
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077611
[TBL] [Abstract][Full Text] [Related]
18. Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach.
Le Large TYS; Meijer LL; Paleckyte R; Boyd LNC; Kok B; Wurdinger T; Schelfhorst T; Piersma SR; Pham TV; van Grieken NCT; Zonderhuis BM; Daams F; van Laarhoven HWM; Bijlsma MF; Jimenez CR; Giovannetti E; Kazemier G
Oncologist; 2020 Apr; 25(4):e634-e643. PubMed ID: 31943574
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
20. A High-Accuracy Model Based on Plasma miRNAs Diagnoses Intrahepatic Cholangiocarcinoma: A Single Center with 1001 Samples.
Hu J; Wang YN; Song DJ; Tan JP; Cao Y; Fan J; Wang Z; Zhou J
Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33805513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
